Our Sponsors
Issue Detection and Escalation in Clinical Trial Settings
Website http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=702261?channel=ourglocal |
Edit Freely
Category Clinical Compliance
Deadline: June 19, 2012 | Date: June 19, 2012
Venue/Country: Palo Alto, U.S.A
Updated: 2012-05-30 19:22:49 (GMT+9)
Call For Papers - CFP
This webinar on issue detection and escalation in clinical trial settings will review the responsibilities of sponsors, investigators, IRB, vendors and CROs in clinical trial setting to maintain compliance. We will discuss how you can proactively monitor to prevent issues and in case of issue detection, escalate them.Why Should You Attend:In recent years the FDA has increased the number of clinical sites and trials that have been inspected and audited. The number of investigators under investigation or disqualified has increased. IRBs have been inspected and issued with 483 letters.Areas Covered in the Seminar:- Checking the investigators and IRB qualifications and training.- Preventive risk mitigation methods including training and monitoring sites.- Considerations for protocol violations.- Issuing protocol deviations.- Communication plans with issue escalations and contingency planning.- Monitor report templates.- Process maps for risk mitigations and action items including escalation.Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.